Loading article…
Synapse bankruptcy froze $200 million in customer assets and erased $95 million; Mercury moves to outrank other claimants as lawsuits mount.
The bankruptcy of fintech‑as‑a‑service provider Synapse has left its former unicorn client Mercury filing motions to jump ahead of other potential creditors, a fight that could determine who recovers any of the $95 million in customer funds estimated missing and the $200 million in assets currently frozen [1].
| At a glance | |
|---|---|
| Missing customer funds | $95 million (court‑appointed trustee estimate) |
| Frozen assets | $200 million |
| Key creditor move | Mercury seeks priority over other claimants |
| Catalyst | Synapse’s April collapse after partner bank Evolve withdrew support |
Synapse, founded in 2014 to connect consumer‑facing apps with banks, filed for bankruptcy in April 2024 after its relationship with regional bank Evolve unraveled. The failure cascaded through dozens of fintech platforms, including Yotta, Juno and teen‑banking app Copper, trapping users’ deposits. Court filings show as many as $95 million in customer money “went missing,” while roughly $200 million in assets were frozen pending resolution [1]. The litigation has attracted a class‑action suit that could involve tens of thousands of users, with individual cases ranging from a $22,000 loss intended for a pet’s chemotherapy to a $21,000 freeze on a payments‑processor’s savings.
Mercury, a high‑growth fintech unicorn that relied on Synapse’s banking‑as‑a‑service platform, has filed to be treated as a senior creditor. By securing priority, Mercury hopes to recover more of its own capital and possibly influence the distribution of any remaining assets to downstream clients. The move pits Mercury against a growing list of claimants—including Yotta users who have received as little as $500 after months of waiting—and underscores the strategic importance of creditor hierarchy in complex fintech bankruptcies [1].
The Synapse saga highlights how intertwined fintech infrastructure can amplify a single partner’s failure into a systemic risk for millions of users, while Mercury’s aggressive legal positioning raises questions about who ultimately bears the cost of such collapses.
Coverage is mostly measured — 8 of 8 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 2 outlets · Jun 18, 2026 · How we report
A report by trustee Jelena McWilliams indicates an $85 million discrepancy between the $265 million in customer balances and the $180 million held by partner banks, but the exact source of the missing funds is still unknown.
More than 100,000 customers of various fintech companies that used Synapse have been locked out of their savings accounts.
The trial showed consistent signals of benefit in functional endpoints, including improved hand grip strength and motor function, with effects persisting up to seven days after treatment ended.
Ignaseclant was reported as well tolerated, with all adverse events classified as mild or moderate and no serious adverse events or discontinuations.
NMD Pharma plans to conduct larger and longer-term studies to further evaluate ignaseclant’s efficacy and safety in Charcot‑Marie‑Tooth disease.